BlackRock
OKUR

BlackRock’s OnKure Therapeutics OKUR Stock Holding History

BlackRock’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.84M Buy
1,499,845
+1,450,258
+2,925% +$6.22M ﹤0.01% 3829
2026
Q1 		$205K Sell
49,587
-3,091
-6% -$9.54K ﹤0.01% 4761
2025
Q4 		$153K Sell
52,678
-512,158
-91% -$1.53M ﹤0.01% 4795
2025
Q3 		$1.55M Buy
564,836
+33
+0% +$82 ﹤0.01% 4171
2025
Q2 		$1.35M Buy
564,803
+475,822
+535% +$1.25M ﹤0.01% 4163
2025
Q1 		$383K Sell
88,981
-5,036
-5% -$28.3K ﹤0.01% 4463
2024
Q4 		$809K Buy
94,017
+71,884
+325% +$1.09M ﹤0.01% 4274
2024
Q3 		$376K Sell
22,133
-7,232
-25% -$107K ﹤0.01% 4395
2024
Q2 		$443K Sell
29,365
-70,001
-70% -$1.19M ﹤0.01% 4373
2024
Q1 		$1.65M Buy
99,366
+1,036
+1% +$17.1K ﹤0.01% 4066
2023
Q4 		$1.57M Buy
98,330
+36,448
+59% +$2.27M ﹤0.01% 4122
2023
Q3 		$4.71M Buy
61,882
+16,189
+35% +$1.1M ﹤0.01% 3676
2023
Q2 		$3M Buy
45,693
+43,329
+1,833% +$3.49M ﹤0.01% 3890
2023
Q1 		$141K Sell
2,364
-66
-3% -$2.39K ﹤0.01% 4882
2022
Q4 		$56.6K Buy
2,430
+50
+2% +$1.33K ﹤0.01% 5192
2022
Q3 		$80K Buy
2,380
+79
+3% +$2.59K ﹤0.01% 5241
2022
Q2 		$61K Sell
2,301
-29,402
-93% -$684K ﹤0.01% 5374
2022
Q1 		$932K Buy
31,703
+15
+0% +$839 ﹤0.01% 4692
2021
Q4 		$2.71M Buy
31,688
+2,260
+8% +$166K ﹤0.01% 4277
2021
Q3 		$2.19M Buy
29,428
+446
+2% +$37.9K ﹤0.01% 4285
2021
Q2 		$2.7M Buy
+28,982
New +$3.23M ﹤0.01% 4140

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BlackRock's OKUR Position: Q2 2026 in Review

BlackRock increased its OnKure Therapeutics (OKUR) stake by 2,925% in Q2 2026, buying an estimated $6.22M and bringing the position to 1,499,845 shares worth $6.84M. The position accounts for ﹤0.01% of the portfolio, ranked #3829.

BlackRock first reported a position in OKUR in Q2 2021 and has held it in 21 quarters since. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

  • BlackRock held 1,499,845 shares of OnKure Therapeutics worth $6.84M as of Q2 2026.
  • BlackRock bought 1,450,258 OnKure Therapeutics shares in Q2 2026, an estimated $6.22M.
  • OnKure Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3829 holding.
  • BlackRock first reported a position in OnKure Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • 75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.